ReviewFrontiers in pharmacology2024

Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application.

Murshid Imam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.